Par-4 as therapy for colon cancer

被引:0
|
作者
Irby, Rosalyn B.
Kline, Christina L.
Sharma, Arun K.
机构
关键词
D O I
10.1158/1538-7445.AM10-1209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1209
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Par-4 for molecular therapy of prostate cancer
    Butler, J
    Rangnekar, VM
    CURRENT DRUG TARGETS, 2003, 4 (03) : 223 - 230
  • [2] Par-4 as a potential target for cancer therapy
    Irby, Rosalyn B.
    Kline, Christina L. B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (01) : 77 - 87
  • [3] PAR-4 as a possible new target for pancreatic cancer therapy
    Azmi, Asfar S.
    Philip, Philip A.
    Zafar, Syed F.
    Sarkar, Fazlul H.
    Mohammad, Ramzi M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (06) : 611 - 620
  • [4] Role of PAR-4 in ovarian cancer
    Meynier, Sonia
    Kramer, Marianne
    Ribaux, Pascale
    Tille, Jean-Christophe
    Delie, Florence
    Petignat, Patrick
    Cohen, Marie
    ONCOTARGET, 2015, 6 (26) : 22641 - 22652
  • [5] Nanoliposomal delivery of Par-4 to colon tumor cells
    Kester, Mark
    Kline, Christina
    Pastor, Danielle
    Lee, Norman
    Irby, Rosalyn
    HUMAN GENE THERAPY, 2008, 19 (10) : 1101 - 1101
  • [6] TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells
    Nguyen, Jeffrey Q.
    Irby, Rosalyn B.
    CANCER BIOLOGY & THERAPY, 2017, 18 (01) : 16 - 25
  • [7] Gastrin signaling and Par-4 in pancreatic cancer
    Fino, Kristin K.
    Irby, Rosalyn B.
    Smith, Jill P.
    CANCER RESEARCH, 2011, 71
  • [8] Radiosensitivity with Par-4 expression in prostate cancer
    Sheikh, MS
    CANCER BIOLOGY & THERAPY, 2002, 1 (02) : 161 - 162
  • [9] Apoptosis by Par-4 in cancer and neurodegenerative diseases
    El-Guendy, N
    Rangnekar, VM
    EXPERIMENTAL CELL RESEARCH, 2003, 283 (01) : 51 - 66
  • [10] Par-4 prevents breast cancer recurrence
    Hebbar, Nikhil
    Shrestha-Bhattarai, Tripti
    Rangnekar, Vivek M.
    BREAST CANCER RESEARCH, 2013, 15 (05)